Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700019267

Trial Profile

Clinical Trials Insight: 700019267

Not stated
Phase of Trial: Phase I

Latest Information Update: 05 Dec 2008

At a glance

  • Drugs AZD 2836 (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Arrow Therapeutics
  • Most Recent Events

    • 05 Dec 2008 Status changed from recruiting to unconfirmed as reported by an AstraZeneca representative (New Zealand).
    • 29 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top